Medincell

Impact with long-acting injectables.
RT is not endorsement

[Medincell @MedinCell]

🗓️ Save the date: #Medincell FY2025–2026 Results
Join our live videoconference on June 16, 2026 to review full-year results.
🕕 6:00 pm CEST / 12:00 pm ET
🎥 Sessions in English & French + dedicated French Q&A
More details 👉https://t.co/pdxDIu3hfB
#FinancialResults #EarningsCall

[Medincell @MedinCell]

📍 @MedinCell at #BIO2026 (San Diego, June 22–25)
Meet our BD & Licensing team to explore partnerships in long-acting therapeutics powered by BEPO®.
Looking to extend asset value or solve drug delivery challenges? 👉Meet us at BIO: https://t.co/kQgI1AXv6L
#Biopharma #DrugDelivery

[Medincell @MedinCell]

@MedinCell will join two upcoming U.S. investor conferences:
📍 Jefferies NY Biotech Conference (June 2–4) -Presentation June 4, 9:55 AM ET (live webcast - link available here: https://t.co/bvyC9yizLl)
📍 Evercore Summer Symposium (June 22–24)

[Medincell @MedinCell]

👉 Watch full Episode: https://t.co/i0sWQ9kSJk

[Medincell @MedinCell]

What if IP wasn’t just about protection-but a driver of innovation and growth?
In our latest #InsideMedincell episode, Dave Martin, Head of IP, explains how intellectual property fuels innovation, partnerships, and long-term impact in biopharma.
👉🎬full video in comments

[Medincell @MedinCell]

Treating schizophrenia is one challenge. Staying on treatment is another.
On #WorldSchizophreniaDay, we highlight the need for solutions that support continuity in real life. Long-acting injectables may help reduce burden and improve adherence.👉 https://t.co/6InFNdBV5d

[Medincell @MedinCell]

@MedinCell at #LAAI2026 🇺🇸
Join us May 20 in Philadelphia for our presentation on advancing long-acting injectables with BEPO® technology.
🔬 From malaria prevention to TB treatment, discover how we enable differentiated anti-infectives.
#LongActing #DrugDelivery #GlobalHealth

[Medincell @MedinCell]

UZEDY® keeps building strong momentum 📈
Q1 2026 U.S. net sales reached $63M: +62% YoY and +15% vs Q4 2025, as adoption continues to accelerate.
A great example of long‑term value creation through partnership.
🔗 https://t.co/tHLoyIvAy1
#Medincell #Teva #UZEDY #MentalHealth

[Medincell @MedinCell]

🎥 Want to learn how formulation turns science into long-acting treatments?
Watch full episode here:
https://t.co/pelLqWFhtH

[Medincell @MedinCell]

𝗪𝗵𝗮𝘁 𝗺𝗮𝗸𝗲𝘀 𝗮 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗹𝗮𝘀𝘁 𝗳𝗼𝗿 𝘄𝗲𝗲𝗸𝘀 - 𝗼𝗿 𝗲𝘃𝗲𝗻 𝗺𝗼𝗻𝘁𝗵𝘀?
In the first episode of 𝘐𝘯𝘴𝘪𝘥𝘦 𝘔𝘦𝘥𝘪𝘯𝘤𝘦𝘭𝘭, Emma Sergo takes us behind the science of formulation.
🎥Full video in comment👇
#Innovation #Biotech #InnovativeTreatments

[Medincell @MedinCell]

Medincell expands its transatlantic analyst coverage:
🇺🇸 Leerink Partners - Outperform, €33 PT
🇪🇺 Degroof Petercam - Buy, €39 PT
Strengthening our visibility accross global capital markets.
🔗 https://t.co/Myk7TAy6QA
#Medincell #Biotech #CapitalMarkets

[Medincell @MedinCell]

How does long-acting #innovation translate into real patient impact?
Join our live R&D Day on May 12 to explore our LAI technologies, pipeline strategy & partnerhsip model.
🔗🎥Access Live & save event to calendar >> https://t.co/cGY8rSI5lZ

#Liveevent #Longactinginjectables

[Medincell @MedinCell]

A new year, a bold #ShiftToGrowth 🚀
Our 135+ Medincell teammates from 25+ nationalities gathered in Montpellier to align on strategy, LAI innovation, and our growth ambition - then wrapped it up with teamwork on the golf course ⛳️
Excited for what’s next!
#PurposefulInnovation

[Medincell @MedinCell]

Advancing the next generation of Long‑Acting Injectables: Medincell will attend PBP World Meeting 2026 with Adolfo López-Noriega, Christophe Roberge & Anthony Rech.
See visual for our talk & session times.
#PBP2026 #Biopharmaceutics #LongActingInjectables #DrugDelivery

[Medincell @MedinCell]

Medincell will be at #BIOEuropeSpring!
James Gubbins, PhD, will be in Lisbon (Mar 23–25) to explore partnerships and present our BEPO® LAI technology.
🤝Want to meet? Contact James via the partnering platform.
#BIO #BIOEurope #Biotech #Pharma #Partnering #BIOEuropeSpring2026

[Medincell @MedinCell]

@MedinCell has raised €48M to advance key programs, boost our LAI platform, and strengthen future partnerships. Thank you to all supporting investors.
🔗 More details: https://t.co/wWG04dk4Gb

[Medincell @MedinCell]

📢 MedinCell HY Results Videoconference

🗓️ Dec 10, 2024
🇫🇷 6 PM CET (French): https://t.co/ZdZmOHHklX
🇬🇧 7 PM CET (English): https://t.co/7miJ2mdMD8
Join us to hear our latest updates.
#MedinCell #HYResults #CorporateEvent

[Medincell @MedinCell]

Participez à notre Webinaire Recherche & Développement le jeudi 10 octobre à 18h00

Pour vous connecter : https://t.co/f4pTnELRff

Vous pouvez envoyer vos questions d'ordre scientifique et médical à [email protected],

[Réunion en français]

[Medincell @MedinCell]

📻 This morning, @christophedouat Douat was featured on @radioclassique , interviewed by @FrancoisGeff. It was a great opportunity to highlight the recent successes of Medincell and share what's coming next.
📢 Tune in to listen to the full interview here: https://t.co/Z80Ynaysjt

[Medincell @MedinCell]

@christophedouat Douat, CEO, and Richard Malamut, CMO, to present Medincell's portfolio and R&D pipeline at the Jefferies Global Healthcare Conference

To access the presentation remotely, either live or on replay: https://t.co/Zy0o2BgqG5

#JefferiesHealthcare